SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015543
Filing Date
2019-08-13
Accepted
2019-08-13 16:31:37
Documents
70
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_yewbiopharmgroup.htm 10-Q 763893
2 CERTIFICATION f10q0619ex31-1_yewbio.htm EX-31.1 10051
3 CERTIFICATION f10q0619ex31-2_yewbio.htm EX-31.2 9984
4 CERTIFICATION f10q0619ex32_yewbio.htm EX-32 5222
  Complete submission text file 0001213900-19-015543.txt   4486400

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20190630.xml EX-101.INS 757124
6 XBRL SCHEMA FILE yewb-20190630.xsd EX-101.SCH 82741
7 XBRL CALCULATION FILE yewb-20190630_cal.xml EX-101.CAL 66446
8 XBRL DEFINITION FILE yewb-20190630_def.xml EX-101.DEF 173592
9 XBRL LABEL FILE yewb-20190630_lab.xml EX-101.LAB 453100
10 XBRL PRESENTATION FILE yewb-20190630_pre.xml EX-101.PRE 296188
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 191021108
SIC: 0100 Agricultural Production-Crops
Assistant Director 5